# A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

> **NCT06987968** · PHASE2 · TERMINATED · sponsor: **Genfit** · enrollment: 3 (actual)

## Conditions studied

- Hepatic Encephalopathy
- Acute on Chronic Liver Failure (ACLF)
- Decompensated Cirrhosis

## Interventions

- **DRUG:** VS-01 on top of SOC (Active Treatment Group)
- **DRUG:** SOC

## Key facts

- **NCT ID:** NCT06987968
- **Lead sponsor:** Genfit
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-08-25
- **Primary completion:** 2025-09-08
- **Final completion:** 2025-09-15
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06987968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06987968, "A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06987968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*